These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15061673)

  • 1. Recurrent Mycobacterium xenopi infection in a patient with rheumatoid arthritis receiving etanercept.
    Yim K; Nazeer SH; Kiska D; Rose FB; Brown D; Cynamon MH
    Scand J Infect Dis; 2004; 36(2):150-4. PubMed ID: 15061673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept.
    Maimon N; Brunton J; Chan AK; Marras TK
    Thorax; 2007 Aug; 62(8):739-40. PubMed ID: 17687101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Mycobacterium xenopi infection in AIDS patients treated with HAART in Hungary.
    Szlávik J; Sárvári C
    Eur J Clin Microbiol Infect Dis; 2003 Nov; 22(11):701-3. PubMed ID: 14557921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review.
    Mori S; Sugimoto M
    Clin Rheumatol; 2012 Feb; 31(2):203-10. PubMed ID: 22170032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy.
    van Ingen J; Boeree M; Janssen M; Ullmann E; de Lange W; de Haas P; Dekhuijzen R; van Soolingen D
    Nat Clin Pract Rheumatol; 2007 Jul; 3(7):414-9. PubMed ID: 17599076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous Mycobacterium chelonae infection in a rheumatoid arthritis patient treated with etanercept.
    Hamaguchi Y; Fujimoto M; Oishi K; Kitajima S; Wada T; Takehara K
    Eur J Dermatol; 2013; 23(5):700-1. PubMed ID: 24135619
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycobacterium heckeshornense lumbar spondylodiskitis in a patient with rheumatoid arthritis receiving etanercept treatment.
    Elyousfi AA; Leiter JR; Goytan MJ; Robinson DB
    J Rheumatol; 2009 Sep; 36(9):2130-1. PubMed ID: 19738230
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrence of alopecia areata in a patient receiving etanercept injections.
    Posten W; Swan J
    Arch Dermatol; 2005 Jun; 141(6):759-60. PubMed ID: 15967923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of anti-TNF therapy to reactivate previously septic prosthetic joints.
    Manolios N; Burneikis A; Spencer D; Howe G
    BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23839609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium heckeshornense lung infection that was diagnosed as Mycobacterium xenopi disease by DNA-DNA hybridization (DDH).
    Morimoto K; Kazumi Y; Maeda S; Yoshimori K; Yoshiyama T; Ogata H; Kurashima A; Kudoh S
    Intern Med; 2011; 50(11):1251-3. PubMed ID: 21628944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept and infliximab associated with cutaneous vasculitis.
    McCain ME; Quinet RJ; Davis WE
    Rheumatology (Oxford); 2002 Jan; 41(1):116-7. PubMed ID: 11792895
    [No Abstract]   [Full Text] [Related]  

  • 12. Lichen striatus associated with etanercept treatment of rheumatoid arthritis.
    Lora V; Kanitakis J; Latini A; Cota C
    J Am Acad Dermatol; 2014 Apr; 70(4):e90-e92. PubMed ID: 24629374
    [No Abstract]   [Full Text] [Related]  

  • 13. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
    Smolen JS; Nash P; Durez P; Hall S; Ilivanova E; Irazoque-Palazuelos F; Miranda P; Park MC; Pavelka K; Pedersen R; Szumski A; Hammond C; Koenig AS; Vlahos B
    Lancet; 2013 Mar; 381(9870):918-29. PubMed ID: 23332236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful etanercept use in an HIV-positive patient with rheumatoid arthritis.
    Kaur PP; Chan VC; Berney SN
    J Clin Rheumatol; 2007 Apr; 13(2):79-80. PubMed ID: 17414534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium kansasii cutaneous infection in a patient with sarcoidosis treated with anti-TNF agents.
    Spiliopoulou I; Foka A; Bounas A; Marangos MN
    Acta Clin Belg; 2014 Jun; 69(3):229-31. PubMed ID: 24773076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of rheumatoid arthritis with etanercept].
    Lamprecht P; Nitschmann S
    Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
    [No Abstract]   [Full Text] [Related]  

  • 17. Etanercept treatment of rheumatoid arthritis in the "real world".
    Smith MD
    Ann Rheum Dis; 2003 Jan; 62(1):95-6; author reply 96. PubMed ID: 12480688
    [No Abstract]   [Full Text] [Related]  

  • 18. Relapsing oligoarticular septic arthritis during etanercept treatment of rheumatoid arthritis.
    Mor A; Mitnick HJ; Greene JB; Azar N; Budnah R; Fetto J
    J Clin Rheumatol; 2006 Apr; 12(2):87-9. PubMed ID: 16601543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission in rheumatoid arthritis patients treated with etanercept monotherapy: clinical practice and clinical trial experience.
    Cannon GW; Wang BC; Park GS; Koenig A; Collier DH; Keystone EC
    Clin Exp Rheumatol; 2013; 31(6):919-25. PubMed ID: 24237999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.
    Chen HA; Lin KC; Chen CH; Liao HT; Wang HP; Chang HN; Tsai CY; Chou CT
    Ann Rheum Dis; 2006 Jan; 65(1):35-9. PubMed ID: 15975966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.